IRIS
CARAMORI, Gaetano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.121
NA - Nord America 8.242
AS - Asia 7.666
SA - Sud America 3.652
AF - Africa 218
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 28.915
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.021
RU - Federazione Russa 5.433
BR - Brasile 3.102
SG - Singapore 2.940
CN - Cina 2.329
IE - Irlanda 1.417
HK - Hong Kong 874
VN - Vietnam 682
IT - Italia 638
SE - Svezia 589
FR - Francia 377
AR - Argentina 208
DE - Germania 177
IN - India 137
BD - Bangladesh 111
PL - Polonia 110
EC - Ecuador 98
GB - Regno Unito 85
MX - Messico 81
TR - Turchia 80
CO - Colombia 77
ID - Indonesia 75
CA - Canada 62
FI - Finlandia 62
ZA - Sudafrica 62
IQ - Iraq 60
VE - Venezuela 48
UA - Ucraina 47
PY - Paraguay 42
PK - Pakistan 41
UZ - Uzbekistan 39
MA - Marocco 37
JP - Giappone 34
CL - Cile 29
NL - Olanda 27
AT - Austria 26
BE - Belgio 26
TN - Tunisia 23
KE - Kenya 21
PE - Perù 21
AZ - Azerbaigian 20
JO - Giordania 20
AE - Emirati Arabi Uniti 19
KZ - Kazakistan 19
NP - Nepal 17
EG - Egitto 16
MY - Malesia 16
UY - Uruguay 16
ES - Italia 14
IL - Israele 14
PA - Panama 13
SA - Arabia Saudita 13
AL - Albania 12
DO - Repubblica Dominicana 12
JM - Giamaica 12
OM - Oman 12
PH - Filippine 12
TH - Thailandia 12
BG - Bulgaria 11
BO - Bolivia 11
CZ - Repubblica Ceca 11
SN - Senegal 10
AU - Australia 9
CH - Svizzera 9
DZ - Algeria 9
GE - Georgia 9
HN - Honduras 9
KR - Corea 9
LK - Sri Lanka 9
LT - Lituania 9
TW - Taiwan 9
CI - Costa d'Avorio 8
GR - Grecia 8
KG - Kirghizistan 8
BH - Bahrain 7
CR - Costa Rica 7
ET - Etiopia 7
TT - Trinidad e Tobago 7
AM - Armenia 6
AO - Angola 6
IR - Iran 6
GT - Guatemala 5
PS - Palestinian Territory 5
RS - Serbia 5
SY - Repubblica araba siriana 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
LB - Libano 4
NI - Nicaragua 4
SV - El Salvador 4
BN - Brunei Darussalam 3
CG - Congo 3
EE - Estonia 3
KW - Kuwait 3
LV - Lettonia 3
MK - Macedonia 3
RO - Romania 3
BW - Botswana 2
BZ - Belize 2
Totale 28.881
Salva come PNG Salva come JPEG
Città #
Moscow 2.027
Ashburn 1.527
Dublin 1.417
Singapore 1.166
Hong Kong 870
Dallas 804
Beijing 678
Chandler 537
Dearborn 509
The Dalles 440
Nyköping 397
San Jose 391
Princeton 325
Lauterbourg 277
Jacksonville 270
Ho Chi Minh City 260
São Paulo 252
Des Moines 233
San Mateo 224
Cambridge 219
Messina 199
Los Angeles 192
Medford 167
Hanoi 141
Redondo Beach 128
Jinan 116
Tianjin 113
Shenyang 110
Buffalo 107
Warsaw 106
Rio de Janeiro 94
Belo Horizonte 76
Guangzhou 66
Nanjing 64
New York 64
Curitiba 61
Munich 61
Wilmington 59
Ningbo 58
Zhengzhou 57
Orem 52
Ann Arbor 48
Hebei 47
Santa Clara 46
Brasília 45
Bremen 45
Naples 40
Haikou 39
Porto Alegre 39
Campinas 38
Lanzhou 38
Nanchang 38
Rome 38
Tashkent 38
Hangzhou 37
Pune 37
Shanghai 37
Haiphong 35
Salvador 35
Turku 34
Quito 32
Guarulhos 28
Taizhou 28
Tokyo 28
Baghdad 26
Ribeirão Preto 26
Chennai 25
Bogotá 24
Brooklyn 24
Brussels 24
Da Nang 24
Guayaquil 24
Santo André 24
Jakarta 23
Milan 23
Asunción 22
Council Bluffs 22
Fortaleza 22
Shenzhen 22
Denver 21
Frankfurt am Main 21
Changsha 20
Fuzhou 20
Goiânia 20
Istanbul 20
Johannesburg 20
London 20
Thái Bình 20
Caxias do Sul 19
Maceió 19
Nairobi 19
Baku 18
Cape Town 18
Montreal 18
Recife 18
Sorocaba 18
Betim 17
Buenos Aires 17
Chicago 17
Jiaxing 17
Totale 16.536
Salva come PNG Salva come JPEG
Nome #
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 256
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. 231
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. Basi fisiologiche. I parte. 224
An unusual cause of chest pain 211
AN UNUSUAL CASE OF CHRONIC AIRFLOW OBSTRUCTION IN A HEAVY SMOKER 196
Hereditary hyperhomocysteinemia associated with nephrotic syndrome complicated by artery thrombosis and chronic thromboembolic pulmonary hypertension: A case report 189
A case of fibrosing interstitial pneumonia 188
An unusual cause of dyspnoea in a patient with chronic ischemic heart disease 188
Molecular links between COPD and lung cancer: new targets for drug discovery? 182
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD 176
Role of Stem Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema 175
Autoimmunity and COPD: Clinical Implications 174
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 172
A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis 168
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 167
[Risk of diabetes mellitus during regular long-term inhaled glucocorticoid treatment in COPD patients: narrative review of the literature.] 162
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines 161
Evaluation of Innate Immune Mediators Related to Respiratory Viruses in the Lung of Stable COPD Patients 156
Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance 155
Role of the mucins in pathogenesis of COPD: implications for therapy 155
Bacterial infections in the lungs of patients with systemic autoimmune diseases 155
Role of Atypical Chemokines and Chemokine Receptors Pathways In the Pathogenesis of COPD 152
Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease 151
A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT 151
Immunomodulatory effect of gefitinib in epidermal growth factor receptor tyrosine kinase inhibitors sensitive and resistant Non small cell lung cancer: role of the RNA binding protein HuR 151
Polmonite interstiziale fibrosante da amiodarone 149
2 agonisti inalatori nel trattamento dell’asma bronchiale e delle broncopneumopatie croniche ostruttive. 140
Allergen Responses Modified by a GATA3 DNAzyme 140
Anatomia e fisiologia clinica della pleura. 138
Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients 138
Commentary on "Major Complications Associated with Conventional Transbronchial Needle Aspiration" 137
Ultrasound assessment of diaphragm function in patients with late-onset Pompe disease 137
Posttranscriptional Gene Regulatory Networks in Chronic Airway Inflammatory Diseases: In silico Mapping of RNA-Binding Protein Expression in Airway Epithelium 137
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD 136
Trattamento personalizzato dei pazienti con BPCO in fase stabile [Personalised treatment of stable COPD patients] 134
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. 131
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 129
New drugs under development for COPD 129
Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression. 127
Transcription inhibitors and inflammatory cell activity 127
Gender differences in COPD management in a Sicilian general practice setting: a cohort study evaluating the impact of educational interventions 126
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 124
Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD 124
D-dimer value in the diagnosis of pulmonary embolism — May it exclude only? 120
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine 119
IL-33 immunohistochemical pattern of expression in neoplastic and nonneoplastic peripheral lung tissues of stage 1 o 2 lung adenocarcinoma 119
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 118
Activation of NF-kappaB transcription factor in asthma death 115
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease. 114
Functional role of inflammasome activation in a subset of obese nonsmoking patients with severe asthma 114
TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase 113
Airway obstruction in chronic obstructive pulmonary disease. 113
Treatable traits in COPD patients 112
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 111
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 110
A link between lung injury and inflammatory myopathies: making the diagnosis 110
Asthma under/misdiagnosis in primary care setting: An observational community-based study in Italy 109
Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation 107
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 107
OXIDANTS AND ANTIOXIDANTS | Antioxidants, Nonenzymatic 107
Epithelial Posttranscriptional Gene Regulatory Networks In Chronic Airway Inflammation: In Silico Mapping Of RNA-Binding Protein Expression 103
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 103
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes. 102
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive.Basi fisiologiche. II parte. 102
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease 102
Transcription factors in asthma and COPD 102
Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study. 101
COPD exacerbations: definitions and classifications 101
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 100
Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype? 99
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 98
Oxidative Stress-induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary Disease 97
The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide 97
Differential diagnosis between newly diagnosed asthma and chronic obstructive pulmonary disease using exhaled breath condensate metabolomics: a pilot study 97
Birbeck granules: contribution to the comprehension of intracytoplasmic evolution. 97
Decreased humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease 95
Controllo della broncopneumopatia cronica ostruttiva in Italia 95
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 93
Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study 93
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 93
Asthma death. 93
Interferonopathy: A potential link between innate immunity and autoimmunity in the pathogenesis of COPD 93
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. 92
Kinase targets and inhibitors for the treatment of airway inflammatory diseases: the next Generation of drugs for severe asthma and COPD?. 92
Chronic obstructive pulmonary disease and lung cancer: new molecular insights 92
Attuali progressi nel trattamento dell’asma bronchiale nell’adulto. 91
Malattie virali dell’apparato respiratorio 91
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 91
Regulation of Wnt4 in chronic obstructive pulmonary disease 91
Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. 91
Asthma: a chronic infectious disease? 91
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy. 90
La teofillina nella BPCO: nuove prospettive (3° parte). 89
Asma. 89
Sex differences and disparities in cardiovascular outcomes of COVID-19 88
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease 88
Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs 88
High-Resolution Computed Tomography Quantitation of Emphysema Is Correlated with Selected Lung Function Values in Stable COPD. 88
The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians 88
Molecular pathogenesis of cigarette smoking-induced stable COPD 88
Totale 12.541
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.682
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 0 0 0 0 0 0 26
2021/20221.665 5 65 5 273 27 13 181 87 19 72 335 583
2022/20232.889 365 187 104 152 133 182 35 96 1.547 8 52 28
2023/2024865 52 81 54 84 70 169 24 30 5 27 11 258
2024/20256.085 74 28 80 313 210 55 91 1.419 1.596 357 706 1.156
2025/202615.057 544 1.069 1.450 1.817 967 3.102 1.764 1.527 1.551 589 348 329
Totale 29.444